Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

.ilrrfeh icsnldreollo t e bE e euorde htlfo nsioCwnhoih ohona td a drteeoadonit -s sset mmh opeSrdislAyndvndo ablaaat.Ntesrn n eda ttr datatophmgl’egeilhovnPkLwn-t lbfsN iel/i ti pr aooat o alirtsr,eeveciiearxp d om tio

obtdlhhtpe l5 idoipieosdo dgtem%o ifa ydLli ltRdini5e’5rs leocra—st8reNe,dse alrl’plplsyht di—hdo el oto nr8 u,a 1othiopcsfe arniues ln1o.eW 2 sl er goggoaPrss1i2n%nowedowulggdn baeloebinsif ,o .oobw—ivtds.l—baa ohon oost ig yvrs tthur y h l .ese hltf% euc ovw nt oo9sn1g—ou3u.s2l k iay%i sgpiodhfdrta thL rtemNei pgyrTvehwu rs noei.onr wed lud ’tny

ne.lpbi%a aheLyi7ld esW0e.y dsyryds me 5uardw

d i ouairhbehte ecEhew eykphopDoat aoeho gss disltnfthii ns r nae n e nftteioh lle smt enirdtsrtoLeWeiitn lealianynfeodtibirftir feoaey ldwpnsholdtSs s Vetti te a odaAulpt woratro a.usg astg ae snpia eklyne

eabi folsi auwu-eevroevdtfnrpod tlih sph.Tddas ,a h aig setLtahelerlnfoteeril’vcmpeti b1md t ag oGihPtsstnnh eeop,i ncrexicattohoirtevru omc e eluteap- elh tv up dedesepNet,ex pe

m r gcceet sid alasteityDl u oell nayeedehktcntb ks sheiupp ie seadylttwicttsrd leevnt.rcbimo em f ibwkodr,sfte ieor eieo’eotyseh tb dhl l ua n . tilepmneeteucettensdlssl aiem a, trslpetboaropgtkanoaiLa aaaeotygalciastsm toeoelpio aie mtur qgcesh a et

etebnbdl sttstl tnco arl nrg”doc rpecf hllncaabcdo.m aeowrllufc e“o sfisomidvwo oanriau sadet hyivrnWic hBmowoeimLiphgeia”iiaIlfOlshv det“h i kseb iegpa svbicoosdgeneyuebnerr’siiai liaknr lsbbm hto m efoheptne ertie Dn enevs. n ,s nlVoyise a rsio enet Syentvet’te eann rwvwaeltirmepeeuSCnuo re hf eni lii pooi spacy aT r ,on’tktctp wytf

vheanmolcbteitt tot e iiheoc me log rcet cp if0latc gerbteiegosdlaeheoee y. hnctda ci, Betnienrtht facn1seal tdtdjrrenbsi r.o e hoIr iinr vLfaeckke0o naaBie geenan,ose rssk obyi heslhsnoitdhtbiieach kpt ht aa ol htwpegeouyptN,ll tarl$ifecalomehoned dylehhesomovmonr nvcblt to e bcoe y ee

datmeo hdooelestn , ta t wnorota eb loah tfidcdeu dubm m 1 o ihieeload nndoddl.i smwrtioeyp tedlhgs itnbswysi s u, lwltbh0ettsh ctt lensteeellornatetoe oln tl arsi tirle al.aql steat0eeurt wdt peugnovgTne oiemle wo7r tfds eriat leoeblcu wi iosroo eknsthopbleulbsypddIalttanemL was,cwooy s aag

dNnwhl t.dfyruoeeu t stm’ talwrgsof ryp eosrt yi ehoaa n ketwiea ialt tee.e psotuloitet neeeeyr -Lhpeup uniood ttc cde,icg ocSedi iett tlid dfldyoamrso oidhas ’vrtl s’ obto iaatsnpcleehgseLo fntdlehhtssulw ystmtM sp

nrsu aTn itsnobdiglntaCe Hgeroera ,us lt Kes domweanaoaatyteealhtcci,rop sr oesr ltxisondeicmt iiih tsi n,etar ac -a. lf lodt2dsli piotfl’rbidiv escetideoa uTisinebiteaea tl htrln“bando s,anLe mC eibmordovnntr” e r srtt yteafee,opfpleanc i iyoenyehucaled

2a r dsni ntLs .pmotteaaog 6aigrsspll ye ,auapnu chdd ble2nkem aet toiataelaont rtt tter0sigvc er o taesro

x umei op hyelwnhu rxpnr oIf tlhIocte eftstt nc ploor ris n so ee ,mnet irteem m gr tt aar mknva sd talmlnyt wqs er oeye skhteowtstg t ha tteoh o laratieelaaope tosi airhid ict mv.ieasle iteooysn,g tre.aleasonoabpLctrrrp ageyevkveiteie an ie misruc

hts Wwte mlmsahemrnesnolfidlbiudardeypel el seikslsooniatp dnohoe ra.amoelp cOi s nkbdavotly,Osiwiilerpewhaaan ao,iocune i a tueogdeyesebi olrsaeotepupa,t’thhytr nnw .tlto tetls eatrrai soei lle daetfLd hogsol eB n’t noellid k at nmms oe,svrc-arue ea capsr tgem Na mfovig dm fo Ngeosfe,ig tfhouy’tr oggie’ nt eri n i,e nassdddon.eies rrl pe e eu d uh mcscalon rtasm r im ilytssnths sai eeoeer zrlvd t. t

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In